News


COPD Discharge Bundle Programme Qualitative Report

COPD Discharge Bundle Programme Qualitative Report
News Cardiovascular disease

From 2013 to 2023, Health Innovation KSS ran a large-scale Respiratory Network and the regular calendar highlights were the twice-yearly Respiratory Collaborative events where we would share learning, and support teams in developing quality improvement methods. A focus of the work was related to hospital admissions for Chronic Obstructive Pulmonary Disease (COPD) which at the time, accounted for nearly 50,000 hospital bed days per year in KSS. The aim was to increase the number of patients who received all the elements of the COPD discharge bundle during an acute hospital admission. We have previously presented the impact of this programme of work on patient-related outcomes and now this new qualitative report describes the impact on the clinical teams involved in delivery of care. Overall, there were many positive aspects raised and clinicians describe the significant value of the KSS Respiratory Network’s support.

Ellie Mason, Programme Manager at Health Innovation KSS, said: “This report shares the impact of the KSS COPD Discharge Bundle programme on clinical teams and KSS Respiratory Network members, including their views on the value of the bundle and the support provided by the KSS Respiratory Network. I would like to thank Dr Jo Congleton and Julia Bott for their excellent clinical leadership to the KSS Respiratory Network over many years, as well as our network members for their continued engagement and commitment to improving respiratory care collaboratively, it is great to see the ongoing legacy of our collective work across the region.”

You can read about the programme legacy in the qualitative report here.

Related news

Elekta Unity combines magnetic resonance imaging (MRI) with a medical linear accelerator (linac) to improve precision radiotherapy for cancer, potentially reducing treatment burden for patients while improving outcomes.

Case StudyNews

12 Mar 2025

More

Health Innovation Kent Surrey Sussex (KSS) has appointed Chris Hill as Chief Commercial Officer, joining the executive management group to support the organisation through a period of exciting growth.

News

20 Feb 2025

More

MUTU®, the evidence-based digital postnatal recovery platform, has secured its first NHS contract. The programme will be implemented in Medway...

News

19 Feb 2025

More

The Sussex Health and Care Primary Care Heart Failure Diagnostic and Treatment Pathway is a consolidation of the heart failure diagnostic and treatment pathways, and has now been updated to reflect latest guidance.

News

20 Aug 2024

More

The Kent and Medway InHIP project’s primary aim was to improve access to care, detection and effective management of hypercholesterolemia to reduce risk of CVD morbidity and mortality, with particular focus on improving access to screening and treatment in the Lower Super Output Areas (LSOAs).

Case StudyNews

30 Mar 2024

More

The Surrey Heartlands InHIP project’s primary aim was to increase access to high cholesterol and familial hypercholesterolaemia (FH) screening and associated treatments in the community, focusing on populations from deprived areas, Black and Asian minority ethnic groups, and those ineligible for NHS health checks, largely due to age.

Case StudyNews

30 Mar 2024

More